Access cutting-edge solid tumors treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access solid tumors specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related solid tumors treatment provided free
The primary objective of Part A is to evaluate the safety and tolerability of S-531011 and to determine the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of S-531011. The primary objective of Parts B and C is to evaluate the antitumor activity of S-531011 at the RP2D.
Sponsor: Shionogi
Check if you qualify for this solid tumors clinical trial in Philadelphia, PA
If you're searching for solid tumors treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.